Machine Learning-Enhanced Mucosal Luminal Interface Metaproteomics Reveals Diagnostic Potential of Microbial Proteins in Pediatric Inflammatory Bowel Disease
Year: 2026
Type: preprint
Study design: Observational Study
Abstract: Inflammatory Bowel Disease (IBD), a chronic gastrointestinal disorder with two main subtypes, Crohn’s Disease (CD) and Ulcerative Colitis (UC), is associated greater diagnostic complexity in pediatric patients. Conventional diagnostic biomarkers, lack sufficient distinguishing power between IBD subtypes. This study aimed to investigate and compare proteomic and metaproteomic profiles of pediatric IBD (PIBD) patients and healthy controls to develop a diagnostic panel capable of accurately diagnose IBD and distinguish its subtypes. We performed an in-depth evaluation of mucosal luminal interface samples from PIBD patients and healthy individuals, separately analyzing both the human proteome and microbial metaproteome data. The study involved selecting appropriate protein sets, employing feature selection techniques and machine learning across three intestinal regions: the terminal ileum, ascending colon, and descending colon. Notably, panels composed solely of microbial biomarkers outperformed both human-only and combined human-microbial panels, achieving highly accurate results. Furthermore, the ascending colon emerged as the optimal sampling site. This study uncovered disease relevant signaling pathways and delivered taxonomic as well as functional insights into the microbial dysbiosis of PIBD. A diagnostic panel built around microbial proteins—particularly those originating from the ascending colon—emerges as a promising tool for more precise stratification of PIBD subtypes. Abstract Figure
Language: English
Topic: Inflammatory Bowel Disease
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7233846876
